Global clinical diagnostics market size, share & forecast, 2025

2015 – 2025 GLOBAL CLINICAL DIAGNOSTICS MARKET FORECAST & OPPORTUNITIES

www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING

Scope of Report Product of Interest (POI): Clinical Diagnostics

Global clinical diagnostics market is expected to grow at a formidable rate during the forecast period. The global clinical diagnostics market is driven by increasing prevalence of diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, among others. Furthermore, increase in the number of patients suffering from chronic kidney diseases and cancer is also expected to drive the market for clinical diagnostics during the forecast years. Additionally, benefits such as quick test results, easy procedure of testing, ease of procurement of samples, less pain, among others associated with clinical diagnostics are further anticipated to propel the market through 2025.

Market Segmentation

TYPE OF TEST

APPLICATION •

Infectious Diseases

•

Lipid Panel

•

Metabolic Panel

•

Sepsis

•

Infectious Disease

•

New Corona Virus (COVID-19)

Testing •

Others

PRODUCT

•

AIDS

•

Hepatitis

•

Others

Instruments

•

Cardiology

•

Reagents

•

Cancer

•

Assays

•

Others

•

Kits Software

•

REGION

Year Range Review Period

2015 – 2018 Base Year

2019 Estimated Year

2020

END USER

•

Asia-Pacific

Forecast Period

•

Hospital

•

Europe

•

Diagnostic

•

North America

2021 – 2025

Laboratory

•

South America

Others

•

Middle East & Africa

•

2

Table of Contents S. No.

Contents

1.

Product Overview

2.

Research Methodology

3.

Impact of COVID-19 on Global Clinical Diagnostics Market

4.

Executive Summary

5.

Voice of Customer

6.

5.1.

Brand Awareness (Aided/Unaided)

5.2.

Product Awareness

5.3.

Customer Satisfaction Analysis

5.4.

Pricing Analysis

5.5.

Unmet Needs/Challenges

Page No.

Global Clinical Diagnostics Market Outlook 6.1.

Market Size & Forecast 6.1.1.

6.2.

By Value

Market Share & Forecast 6.2.1.

By Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others)

6.2.2.

By Product (Instruments, Reagents, Assays and Kits Software)

6.2.3.

By Application (Infectious Diseases (Sepsis, New Corona Virus (COVID-19), AIDS & Hepatitis and others), Cardiology, Cancer and Others)

6.2.4.

By End User (Hospital, Diagnostic Laboratory, Others)

6.2.5

By Company (2019)

3

Table of Contents S. No.

Contents 6.2.6.

6.3.

7.

Page No.

By Region (Asia-Pacific, Europe, North America, South America and Middle East & Africa)

Market Attractiveness Index

Asia-Pacific Clinical Diagnostics Market Outlook 7.1.

Market Size & Forecast 7.1.1.

7.2.

7.3.

By Value

Market Share & Forecast 7.2.1.

By Type of Test

7.2.2.

By Product

7.2.3.

By Application

7.2.4.

By End User

7.2.5.

By Country (China, India, Australia, Japan, South Korea)

Asia-Pacific: Country Analysis 7.3.1.

China Clinical Diagnostics Market Outlook 7.3.1.1.

Market Size & Forecast 7.3.1.1.1.

7.3.1.2.

By Value

Market Share & Forecast 7.3.1.2.1.

By Type of Test

7.3.1.2.2.

By Product

7.3.1.2.3.

By Application

7.3.1.2.4.

By End User

4

Table of Contents S. No.

Contents 7.3.2.

India Clinical Diagnostics Market Outlook

7.3.2.1.

Market Size & Forecast 7.3.2.1.1.

7.3.2.2.

7.3.3.

By Value

Market Share & Forecast 7.3.2.2.1.

By Type of Test

7.3.2.2.2.

By Product

7.3.2.2.3.

By Application

7.3.2.2.4.

By End User

Australia Clinical Diagnostics Market Outlook 7.3.3.1.

Market Size & Forecast 7.3.3.1.1.

7.3.3.2.

7.3.4.

Page No.

By Value

Market Share & Forecast 7.3.3.2.1.

By Type of Test

7.3.3.2.2.

By Product

7.3.3.2.3.

By Application

7.3.3.2.4.

By End User

Japan Clinical Diagnostics Market Outlook

5

Table of Contents S. No.

Contents 7.3.4.1.

Market Size & Forecast 7.3.4.1.1.

7.3.4.2.

7.3.5.

By Value

Market Share & Forecast 7.3.4.2.1.

By Type of Test

7.3.4.2.2.

By Product

7.3.4.2.3.

By Application

7.3.4.2.4.

By End User

South Korea Clinical Diagnostics Market Outlook 7.3.5.1.

Market Size & Forecast 7.3.5.1.1.

7.3.5.2.

8.

Page No.

By Value

Market Share & Forecast 7.3.5.2.1.

By Type of Test

7.3.5.2.2.

By Product

7.3.5.2.3.

By Application

7.3.5.2.4.

By End User

Europe Clinical Diagnostics Market Outlook

6

Table of Contents S. No.

Contents 8.1.

Market Size & Forecast 8.1.1.

8.2.

8.3.

Page No.

By Value

Market Share & Forecast 8.2.1.

By Type of Test

8.2.2.

By Product

8.2.3.

By Application

8.2.4.

By End User

8.2.5.

By Country (France, Germany, United Kingdom, Italy, Spain)

Europe: Country Analysis 8.3.1.

France Clinical Diagnostics Market Outlook 8.3.1.1.

Market Size & Forecast 8.3.1.1.1.

8.3.1.2.

By Value

Market Share & Forecast 8.3.1.2.1.

By Type of Test

8.3.1.2.2.

By Product

8.3.1.2.3.

By Application

7

Table of Contents S. No.

Contents 8.3.1.2.4.

8.3.2.

By End User

Germany Clinical Diagnostics Market Outlook

8.3.2.1.

Market Size & Forecast 8.3.2.1.1.

8.3.2.2.

8.3.3.

Page No.

By Value

Market Share & Forecast 8.3.2.2.1.

By Type of Test

8.3.2.2.2.

By Product

8.3.2.2.3.

By Application

8.3.2.2.4.

By End User

United Kingdom Clinical Diagnostics Market Outlook 8.3.3.1.

Market Size & Forecast 8.3.3.1.1.

8.3.3.2.

By Value

Market Share & Forecast 8.3.3.2.1.

By Type of Test

8.3.3.2.2.

By Product

8.3.3.2.3.

By Application

8.3.3.2.4.

By End User

8

Table of Contents S. No.

Contents 8.3.4.

Italy Clinical Diagnostics Market Outlook 8.3.4.1.

Market Size & Forecast 8.3.4.1.1.

8.3.4.2.

8.3.5.

By Value

Market Share & Forecast 8.3.4.2.1.

By Type of Test

8.3.4.2.2.

By Product

8.3.4.2.3.

By Application

8.3.4.2.4.

By End User

Spain Clinical Diagnostics Market Outlook 8.3.5.1.

Market Size & Forecast 8.3.5.1.1.

8.3.5.2.

9.

Page No.

By Value

Market Share & Forecast 8.3.5.2.1.

By Type of Test

8.3.5.2.2.

By Product

8.3.5.2.3.

By Application

8.3.5.2.4.

By End User

North America Clinical Diagnostics Market Outlook 9.1.

Market Size & Forecast

9

Table of Contents S. No.

Contents 9.1.1.

9.2.

9.3.

Page No.

By Value

Market Share & Forecast 9.2.1.

By Type of Test

9.2.2.

By Product

9.2.3.

By Application

9.2.4.

By End User

9.2.5.

By Country (United States, Canada, Mexico)

North America: Country Analysis 9.3.1.

United States Clinical Diagnostics Market Outlook 9.3.1.1.

Market Size & Forecast 9.3.1.1.1.

9.3.1.2.

9.3.2.

By Value

Market Share & Forecast 9.3.1.2.1.

By Type of Test

9.3.1.2.2.

By Product

9.3.1.2.3.

By Application

9.3.1.2.4.

By End User

Canada Clinical Diagnostics Market Outlook

10

Table of Contents S. No.

Contents 9.3.2.1.

Market Size & Forecast 9.3.2.1.1.

9.3.2.2.

9.3.3.

By Value

Market Share & Forecast 9.3.2.2.1.

By Type of Test

9.3.2.2.2.

By Product

9.3.2.2.3.

By Application

9.3.2.2.4.

By End User

Mexico Clinical Diagnostics Market Outlook 9.3.3.1.

Market Size & Forecast 9.3.3.1.1.

9.3.3.2.

10.

Page No.

By Value

Market Share & Forecast 9.3.3.2.1.

By Type of Test

9.3.3.2.2.

By Product

9.3.3.2.3.

By Application

9.3.3.2.4.

By End User

South America Clinical Diagnostics Market Outlook 10.1.

Market Size & Forecast 10.1.1.

10.2.

By Value

Market Share & Forecast

11

Table of Contents S. No.

Contents

10.3.

10.2.1.

By Type of Test

10.2.2.

By Product

10.2.3.

By Application

10.2.4.

By End User

10.2.5.

By Country (Brazil, Argentina, Colombia)

Page No.

South America: Country Analysis 10.3.1.

Brazil Clinical Diagnostics Market Outlook 10.3.1.1.

Market Size & Forecast 10.3.1.1.1

10.3.1.2.

10.3.2.

By Value

Market Share & Forecast 10.3.1.2.1.

By Type of Test

10.3.1.2.2.

By Product

10.3.1.2.3.

By Application

10.3.1.2.4.

By End User

Argentina Clinical Diagnostics Market Outlook 10.3.2.1.

Market Size & Forecast 10.3.2.1.1

10.3.2.2.

By Value

Market Share & Forecast 10.3.2.2.1.

By Type of Test

10.3.2.2.2.

By Product

10.3.2.2.3.

By Application

12

Table of Contents S. No.

Contents 10.3.2.2.4.

10.3.3.

By End User

Colombia Clinical Diagnostics Market Outlook 10.3.3.1.

Market Size & Forecast 10.3.3.1.1

10.3.3.2.

11.

Page No.

By Value

Market Share & Forecast 10.3.3.2.1.

By Type of Test

10.3.2.2.2.

By Product

10.3.2.2.3.

By Application

10.3.2.2.4.

By End User

Middle East & Africa Clinical Diagnostics Market Outlook 11.1.

Market Size & Forecast 11.1.1.

11.2.

11.3.

By Value

Market Share & Forecast 11.2.1.

By Type of Test

11.2.2.

By Product

11.2.3.

By Application

11.2.4.

By End User

11.2.5.

By Country (South Africa, Saudi Arabia, UAE, Kuwait)

Middle East & Africa : Country Analysis

13

Table of Contents S. No.

Contents 11.3.1.

South Africa Clinical Diagnostics Market Outlook 11.3.1.1.

Market Size & Forecast 11.3.1.1.1.

11.3.1.2.

11.3.2.

By Value

Market Share & Forecast 11.3.1.2.1.

By Type of Test

11.3.1.2.2.

By Product

11.3.1.2.3.

By Application

11.3.1.2.4.

By End User

Saudi Arabia Clinical Diagnostics Market Outlook 11.3.2.1.

Market Size & Forecast 11.3.2.1.1.

11.3.2.2.

11.3.3.

Page No.

By Value

Market Share & Forecast 11.3.2.2.1.

By Type of Test

11.3.2.2.2.

By Product

11.3.2.2.3.

By Application

11.3.2.2.4.

By End User

UAE Clinical Diagnostics Market Outlook

11.3.3.1.

Market Size & Forecast 11.3.3.1.1.

11.3.3.2.

By Value

Market Share & Forecast

11.3.3.2.1.

By Type of Test

14

Table of Contents S. No.

Contents

11.3.4.

11.3.3.2.2.

By Product

11.3.3.2.3.

By Application

11.3.3.2.4.

By End User

Kuwait Clinical Diagnostics Market Outlook 11.3.4.1.

Market Size & Forecast 11.3.4.1.1.

11.3.4.2.

12.

Page No.

By Value

Market Share & Forecast 11.3.4.2.1.

By Type of Test

11.3.4.2.2.

By Product

11.3.4.2.3.

By Application

11.3.4.2.4.

By End User

Market Dynamics 12.1.

Drivers

12.2.

Challenges

13.

Market Trends & Developments

14.

Competitive Landscape 14.1.

Competition Outlook

14.2.

Global Players Profiled (Leading Companies)

15.

Strategic Recommendations

16.

About Us & Disclaimer

15

RESEARCH METHODOLOGY

Research Methodology

Market Profiling

In-depth secondary research was conducted to determine top players in the global clinical diagnostics market, overall market size and segmental market size.

Formulating Questionnaire

In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.

Developing List of Respondents

Data Collection

Data Validation

Data obtained as a result of primary and secondary research was validated through rigorous triangulation.

TechSci conducted interviews with industry experts and industry players for data collection and verification.

List of industry players and industry specialists was developed.

Primary Research

Data Collection

Data Filter & Analysis

Research & Intelligence

Actionable Insights

Business Solution

LinkedIn TechSci Internal Database

✓ Recent Developments ✓ Market Changing Aspects/Dynamics ✓ Government Policies ✓ Conclusion

✓ Identifying Key Opinion Leaders ✓ Questionnaire Design ✓ In-depth Interviews

Primary Research ✓ ✓

Desk Research

Secondary Research ✓ ✓ ✓ ✓ ✓ ✓ ✓

Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc.

Data Analysis

The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global clinical diagnostics market.

Company Analysis ✓ Market Participants ✓ Key Strengths

Paid Sources

✓ ✓

Factiva Hoovers

17

Research Methodology Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of the global clinical diagnostics market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increasing prevalence of diseases caused due to sedentary lifestyle. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global clinical diagnostics market.

Methodology Followed for Calculation of Market Size:

•

Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as clinical diagnostics companies, channel partners, market influencers & end-users, industry experts, and other industry participants.

•

The team interviewed more than 15 – 20 clinical diagnostics companies, 100 – 120 end-users, and 15 – 20 industry experts and other value chain stakeholders in the global clinical diagnostics market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-2019.

18

Research Methodology •

Respondents were asked about the current and future market growth rates, market shares by type of test, by product, by application, by end user, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.

Methodology Followed for Calculation of Market Shares: •

Market share by type of test, by product, by application, by end user, by company and by region were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of clinical diagnostics markets. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting: •

TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.

•

Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global clinical diagnostics market, TechSci Research used various forecast techniques such as: ✓

Moving Average

✓

Time Series Analysis

✓

Regression Analysis

✓

Econometric and Judgmental Analysis

19

Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.

Partial List of Companies Interviewed

Key Secondary Sources

•

Abbott Laboratories

▪ World Bank

•

BioMérieux

▪ TechSci Research Proprietary Database & Knowledge

•

Bio-Rad Laboratories Inc.

•

Danaher Corporation

•

Becton

•

Dickinson and Company

•

Qiagen

•

Roche Diagnostics

•

Thermo Fisher Scientific, Inc.

•

Sysmex Corporation

Repository ▪ Company Annual Reports ▪ Industry Magazines ▪ Industry Reports ▪ News Dailies ▪ Credible Paid Databases

20

INDUSTRY BRIEF According to TechSci Research report, “Global Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Technique (Immunodiagnostics (ELISA, Western Blot, Radioimmunoassay, Hematology, Others), Molecular Diagnostics (PCR, Microarrays, Hybridization, DNA Diagnostics, Others), Microbiology, Tissue Diagnostics, Clinical Chemistry, Others), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial Resistance, HAIs, Others), Cardiovascular Emergencies, Personalized Medicine, Others(Industrial Applications (Agri-food sector, Biopharma, Cosmetics)), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, Academic & Medical Schools, Others), By Region, Forecast & Opportunities, 2025”, the global clinical diagnostics market is expected to grow at a formidable rate during the forecast period on account of the growing awareness among the patients pertaining to different types of diagnostic tests and procedures. Additionally, increased adoption of automated platforms in the healthcare industry is expected to propel the market during the next five years. Furthermore, increase in the number of diagnostic centers, point of care testing centers, hospitals, among others is adding to and enhancing the quality of existing healthcare services across the globe, which is further projected to promote the market growth over the course of next five years.

Moreover, supportive government policies & schemes for spreading awareness pertaining to various diseases and their diagnosis is expected to foster the growth of market across the globe.

Additionally, governments across various economies are heavily investing in the healthcare industry and R&D activities for development of specialty drugs. However, affordability issues associated with high-end diagnostics can hamper the growth of market during forecast period. Additionally, stringent government regulations on the manufacturing of diagnostic products are also expected to slow down the growth of market. Furthermore, inadequate and tedious reimbursement procedures are also negatively impacting the growth of market during the next five years.

Abbott Laboratories, bioMérieux, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics, Thermo Fisher Scientific, Inc., Sysmex Corporation and others are some of the leading players operating in global clinical diagnostics market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in November 2018, Roche Diagnostics launched VENTANA pan-TRK (EPR17341) Assay for global distribution. It is the first automated IVD immunohistochemistry assay used for the detection of tropomyosin receptor kinase in cancer patients. For instance, in August 2018, Sysmex Corporation and JVC Kenwood Corporation agreed to jointly establish a new company Creative Nano systems Corporation to develop and manufacture biodevices.

“Asia-Pacific is expected to witness significant growth in the clinical diagnostics market during the forecast period, owing to the increasing prevalence of chronic diseases and ageing population.

Additionally, growing pollution levels in countries like India and China has increased the chances for outburst of severe diseases, thereby resulting in increased demand for diagnostic services and preventive care. Furthermore, technological advancements have led the diagnostic sector growing and evolving very rapidly in the region, which can further strengthen the diagnostics sector in the healthcare system and make diagnostic services available to general population at affordable prices.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

21

Competitor Profile Abbott Laboratories Global Clinical Diagnostics Market Size, By Value (USD Million), 2015-2025F

5.00

2015

7.00

6.00

CAGR By Value

XX%

8.00

9.00

10.00

2019

2020E

11.00

14.00

13.00

12.00

CAGR By Value

2025F

YY%

By Value (USD Million)

15.00

North America Clinical Diagnostics Market Share, By Type of Test, By Value, 2015–2025F Lipid Panel 2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Metabolic Panel

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Infectious Disease Testing

Others

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

United States Clinical Diagnostics Market Share, By Product, By Value, 2015–2025F Instruments 2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Reagents

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Assays

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

Kits Software

25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%

22

Competitor Profile Abbott Laboratories

Report Name: GLOBAL CLINICAL DIAGNOSTICS MARKET FORECAST & OPPORTUNITIES 2015 – 2025

Report Price License Type

Price

Electronic Access - Single User License

$4450

Electronic Access - Multi-User License

$5450

Custom Research License

$9450

To View Sample OR Purchase Report

23

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting

Modes use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.

Related Reports

•

Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025

•

Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management, Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Test Type (Disposable and Reusable), By End User (Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025

TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Europe

54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Asia-Pacific

B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com

Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand.

However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.